Man Group PLC Seer, Inc. Transaction History

Man Group PLC

$36 Billion
Q3 2024

A detailed history of Man Group PLC transactions in Seer, Inc. stock. As of the latest transaction made, Man Group PLC holds 201,797 shares of SEER stock, worth $490,366. This represents 0.0% of its overall portfolio holdings.

Number of Shares

201,797

Previous 360,901 44.09%

Holding current value

$490,366

Previous $606,000 34.82%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$1.59 - $2.07 $252,975 - $329,345	-159,104 Reduced 44.09%	201,797 $395,000
Q2 2024 Aug 14, 2024	SELL	$1.65 - $2.24 $238,118 - $323,263	-144,314 Reduced 28.56%	360,901 $606,000
Q1 2024 May 15, 2024	BUY	$1.54 - $2.09 $309,963 - $420,664	201,275 Added 66.22%	505,215 $959,000
Q4 2023 Feb 14, 2024	BUY	$1.47 - $2.22 $99,508 - $150,278	67,693 Added 28.65%	303,940 $589,000
Q3 2023 Nov 14, 2023	BUY	$2.18 - $5.52 $352,076 - $891,496	161,503 Added 216.07%	236,247 $522,000
Q2 2023 Aug 14, 2023	BUY	$3.16 - $4.96 $91,295 - $143,299	28,891 Added 63.01%	74,744 $319,000
Q1 2023 May 15, 2023	BUY	$3.6 - $5.88 $104,126 - $170,073	28,924 Added 170.85%	45,853 $176,000
Q4 2022 Feb 14, 2023	BUY	$5.03 - $8.58 $85,152 - $145,250	16,929 New	16,929 $98,000
Q1 2022 May 16, 2022	SELL	$11.88 - $23.4 $155,271 - $305,838	-13,070 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$21.08 - $38.51 $21,080 - $38,510	1,000 Added 8.29%	13,070 $298,000
Q3 2021 Nov 15, 2021	BUY	$27.67 - $45.04 $333,976 - $543,632	12,070 New	12,070 $417,000
Q2 2021 Aug 16, 2021	SELL	$28.75 - $56.92 $180,320 - $357,002	-6,272 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$38.67 - $84.06 $242,538 - $527,224	6,272 New	6,272 $314,000

Others Institutions Holding SEER

# of Institutions

Shares Held

35.2M

Call Options Held

Put Options Held

600

View Full List

About Seer, Inc.

Ticker SEER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,566,500
Market Cap $142M
Description
Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic res...

More about SEER

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.

Account